Richard Goldberg
Jun 26, 2025, 07:11
Richard Goldberg Brings Three Decades of Unwavering Dedication to Advancing Colorectal Cancer Treatment – Agenus
Agenus shared a post on LinkedIn:
“Dr. Richard Goldberg, Agenus Chief Development Officer, brings three decades of unwavering dedication to advancing colorectal cancer treatment.
From his foundational work in academia and consulting with medical experts to his leadership role with patient advocacy group Fight Colorectal Cancer, Dr. Goldberg’s commitment to patients remains steadfast. As he puts it: “We have to go farther” to address the critical unmet need for life-saving CRC treatments.
Learn about our commitment to creating enhanced CRC treatment options below or on our website.”
More posts featuring Agenus on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34